Trials / Unknown
UnknownNCT00375687
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
Investigation of Early Hormonotherapy Efficacy of High Risk Patients for Progression of Prostate Cancer After Radical Prostatectomy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (planned)
- Sponsor
- Kaunas University of Medicine · Academic / Other
- Sex
- Male
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether early hormonotherapy is effective in the treatment of high risk prostate cancer patients after radical prostatectomy.
Detailed description
The primary purpose of this study is to evaluate the hypothesis, that early administration of adjuvant hormonotherapy (triptorelin) can prolong survival data for high risk patients. Control group (randomised study) will be treated with hormonotherapy, when PSA recidive appear (on demand treatment). Secondary purposes will be to compare PSA dinamics and quality of life data in the groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triptorelin |
Timeline
- Start date
- 2005-08-01
- Completion
- 2020-01-01
- First posted
- 2006-09-13
- Last updated
- 2006-09-13
Locations
1 site across 1 country: Lithuania
Source: ClinicalTrials.gov record NCT00375687. Inclusion in this directory is not an endorsement.